Fig. 3
From: POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma
A nomogram based on the POD24 combined with clinical factors signature. (A) Construction of a nomogram to forecast 3- and 5-years survival by the model. (B) The calibration chart shows that the predicted survival rate is consistent with the actual survival rate for 3-years and 5-years.
